Dapagliflozin Added to Glimepiride in Patients with Type 2 Diabetes Mellitus Sustains Glycemic Control and Weight Loss Over 48 Weeks: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial
Crossref DOI link: https://doi.org/10.1007/s13300-014-0072-0
Published Online: 2014-06-12
Published Print: 2014-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Strojek, Krzysztof
Yoon, Kun-Ho
Hruba, Veronika
Sugg, Jennifer
Langkilde, Anna Maria
Parikh, Shamik
Text and Data Mining valid from 2014-06-01
Article History
Received: 3 April 2014
First Online: 12 June 2014